Elizabeth Halloran

Professor, Epidemiology
Professor, Biostatistics
Adjunct Professor, Applied Mathematics



BS General Science, University of Oregon, 1972
MD Medicine, Freie University of Berlin (Germany), 1983
MPH Tropical Public Health, Harvard University, 1985
DSc Population Sciences, Harvard University, 1989



View Website »

Research Interests

Developing novel designs, methods of statistical analysis, and interpretation of vaccine field studies and other interventions; causal inference

Recent Publications (PubMed)

Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study.
(2022 Nov 18)
Gozzi N, Chinazzi M, Dean NE, Longini IM, Halloran ME, Perra N, Vespignani A

Spillover Benefit of Pre-Exposure Prophylaxis for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model.
(2022 Oct 28)
Epidemiol Infect
Buchanan AL, Park CJ, Bessey S, Goedel WC, Murray EJ, Friedman SR, Halloran ME, Katenka NV, Marshall BDL

Evolutionary consequences of delaying intervention for monkeypox.
(2022 Oct 8)
Lancet 400(10359): 1191-1193
Johnson PLF, Bergstrom CT, Regoes RR, Longini IM, Halloran ME, Antia R

Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs.
(2022 Aug 6)
AIDS Behav
Aroke H, Buchanan A, Katenka N, Crawford FW, Lee T, Halloran ME, Latkin C

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
(2022 Dec)
Clin Trials 19(6): 647-654
Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola V, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo AM

Show complete publication list